Bearish
1
Neutral
8
Bullish
5
Bearish
7
Neutral
8
Bullish
31
Bearish
6
Neutral
0
Bullish
26
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Price, EPS and Revenue Projections
Strong Buy
9
Buy
7
Hold
2
Sell
1
Strong Sell
0
updated on
Nov 14, 2025
No. of Analysts
1Y Price Target
Q3 EPS Estimate
Q3 Revenue Estimate
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Get In-depth insights on EPS and Revenue forecasts
Pharmaceuticals
Pharmaceuticals - Indian - Formulations
32,971 Cr
Low Risk
33.9
43.8
2.8
7.6
3,115.00
2,022.05
Sales CAGR
1Y
10.44%
3Y
11.23%
5Y
14.50%
10Y
11.88%
Profit CAGR
1Y
12.77%
3Y
8.40%
5Y
15.76%
10Y
9.01%
ROE
TTM
22.56%
3Y
21.63%
5Y
21.71%
10Y
22.24%
ROCE
TTM
27.85%
3Y
27.27%
5Y
27.52%
10Y
28.53%
Performance
STEADY PERFORMER
Valuation
OVERVALUED
Growth
STABLE
Profitability
HIGH MARGIN
Technicals
Bullish
Risk
MODERATE RISK

Market Cap
₹ 32,971 Cr
P/E
33.86
Turned 1 L into 2.35 L in last 5 Years